AVGR (Avinger, Inc) Company Projected Revenue

Brandmark of Avinger, Inc (AVGR)

Avinger, Inc. (AVGR) focuses on the mass adoption of the mature Pantheris technology for arterial therapy. The firm's expected implementation level helps track the dynamics of this sector, with the value of 0.01 characterizing this level. Revenues are based on the sale of atherectomy systems for vessel clearing. Innovative catheters with OCT imaging allow surgeons to monitor the plaque removal process in real time.

AVGR - Avinger Inc Company Expected Sales Volume over the range 07/04/2022 - 02/22/2025

Analytical breakdowns and data insights for company Avinger, Inc (AVGR)

- current price and projected stock value:
Fundamental company analysis:avinger.com
Brand item of Avinger Inc.

This metric assesses expected revenue, identifying the gap between market expectations and actual operational activity. For Avinger, Inc. (AVGR), this is critical due to the complexity of the commercial implementation of vascular imaging systems. The trend in the company's future sales indicator exposes hidden business degradation despite static quotes. Analysis of this chart allows for the separation of management's technical competence from real market demand. The indicator serves as an objective filter for investment risks.

Analysis of competing companies

Company Future Sales Volume DXCM (Dexcom)|Company Future Sales Volume Penumbra PEN|Company Projected Revenue Novanta Photonics NOVT|Haemonetics Corp. (HAE) - Company Expected Sales Volume|Inspire Medical - Projected Sales Volume|Company Expected Sales Volume PROCEPT BioRobotics|CNMD: Projected Sales Volume|Company Revenue Forecast PLSE|INMD (InMode MD) - Projected Sales Volume|Company Future Sales Volume Picard Medical Inc. (PMI)|Projected Sales Volume SRDX|Company Future Sales Volume Senseonics Holdings SENS|Projected Sales Volume NPCE (neuropace.com)|Projected Sales Volume Tactile Systems Technology TCMD|SNWV - Company Projected Revenue|Company Expected Sales Volume Outset Medical Corp|ELMD (Electromed Inc) - Company Future Sales Volume|LENSAR, Inc. - Company Future Revenue|RCEL (AVITA Medical Inc) - Projected Sales Volume|Company Expected Sales Volume profoundmedical.com PROF|Company Projected Revenue Baird Medical (BDMD)|EDAP Medical (EDAP) - Company Sales Forecast|Apyx Medical Corp - Company Future Sales Volume|Projected Sales Volume IceCure Medical, Ltd. ICCM|Pulmonx Corp - Projected Sales Volume|Company Future Sales TELA Bio TELA|CytoSorbents Corporation (CTSO) - Company Projected Revenue|Company Expected Revenue SRTS (Sensus)|Company Projected Revenue zynex.com|Company Future Sales Volume electroCore, Inc. (ECOR)|Projected Sales Volume RBOT|IINN - Company Expected Sales Volume|SeaStar Medical - Company Future Sales Volume|IRIX: Company Revenue Forecast|INBS: Company Future Sales Volume|beyondair.net - Company Projected Revenue Volume|Profusa Inc (PFSA) - Company Projected Revenue|SSKN - Company Future Sales|Company Projected Revenue GlucoTrack|Projected Sales Volume NanoVibronix Inc.|Company Projected Revenue Venus Concept (VERO)|Company Future Sales Volume Nuwellis, Inc. NUWE|Projected Sales Volume AEMD (Aethlon Medical, Inc.)|ASXC: Company Revenue Forecast|BioSig Technologies, Inc - Projected Sales Volume|Company Future Revenue CUTR (Cutera, Inc)|KNW: Projected Sales Volume|inarimedical.com - Company Future Revenue|NVRO (Nevro Corp) - Projected Sales Volume|Company Expected Sales Volume ReShape Lifesciences Inc. RSLS|Projected Sales Volume SILK